Trial intelligence / Profile preview

Early verapamil and glyceryl trinitrate for STEMI before primary PCI

ACTRN12606000232538Phase 3Completed

Sponsor
The Queen Elizabeth Hospital,Cardiology Unit
Start
Oct 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Verapamil + glyceryl trinitrate with Saline placebo control (2 arms). Primary endpoint: Angiographic TIMI-3 flow. Started Oct 2005; status: completed.

02

Drugs

verapamilnitroglycerin
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on ACTRN12606000232538.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12606000232538.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call